Vaccination barriers and opportunities at syringe services programs in the United States, June-August 2021-A cross-sectional survey

被引:15
作者
Montgomery, Martha P. [1 ,5 ]
Zhong, Yuna [1 ]
Roberts, Emma [2 ]
Asher, Alice [1 ]
Bixler, Danae [1 ]
Doshani, Mona [1 ]
Christensen, Aleta [1 ]
Eckert, Maribeth [3 ]
Weng, Mark K. [1 ]
Carry, Monique [4 ]
Samuel, Christina R. [1 ]
Teshale, Eyasu H. [1 ]
机构
[1] Ctr Dis Control & Prevent, Div Viral Hepatitis, 1600 Clifton Rd, Atlanta, GA 30329 USA
[2] Natl Harm Reduct Coalit, 22 West 27th St,5th Floor, New York, NY 10001 USA
[3] Ctr Dis Control & Prevent, Immunizat Serv Div, 1600 Clifton Rd, Atlanta, GA 30329 USA
[4] Ctr Dis Control & Prevent, Div Global HIV & TB, 1600 Clifton Rd, Atlanta, GA 30329 USA
[5] 1600 Clifton Rd,MS 12-3, Atlanta, GA 30329 USA
关键词
Vaccination; Syringe exchange programs; Drug user; Hepatitis A; Hepatitis B; COVID-19; HEPATITIS-B VACCINATION; INJECTION-DRUG USERS; RANDOMIZED CONTROLLED-TRIAL; BUPRENORPHINE TREATMENT; COVID-19; VACCINATION; PREVENTION SERVICES; PEOPLE; HEALTH; LESSONS; ACCESS;
D O I
10.1016/j.drugalcdep.2022.109540
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Syringe services programs (SSPs) are an important venue for reaching people who inject drugs (PWID) to offer preventive services; however, not all SSPs offer vaccinations. We aimed to describe barriers and opportunities for SSPs to offer vaccinations. Methods: During June-August 2021, we conducted a descriptive, cross-sectional survey of SSP providers in the United States. SSPs were recruited from national listservs using purposive sampling to ensure geographic diversity. The survey included questions about SSP characteristics, client demographics, existing vaccination resources, resource needs, and staff perspectives on client vaccination barriers. Statistical comparisons were made using Pearson's chi-square test. Results: In total, 105 SSPs from 34 states responded to the survey; 46 SSPs (43.8%) offered on-site vaccinations. SSPs without on-site vaccinations were more likely operated by community-based organizations (81.4% vs 30.4%, p < 0.001) in urban areas (71.4% vs 40.0%, p = 0.002) than SSPs offering on-site vaccinations. The most common staffing need was for personnel licensed to administer vaccines (74/98, 75.5%). Over half of SSPs reported vaccine supply, administration supplies, storage equipment, and systems to follow-up clients for multi dose series as important resource needs. The most common resource need was for reminder/recall systems for vaccines with multidose series (75/92, 81.5%). Vaccine safety concerns (92/95, 96.8%) and competing priorities (92/96, 95.8%) were the most common staff-reported client barriers to vaccinations. Conclusions: Addressing missed opportunities for offering vaccinations to PWID who use SSPs will require increased numbers of on-site personnel licensed to administer vaccines and additional training, vaccination supplies, and storage and handling equipment.
引用
收藏
页数:9
相关论文
共 46 条
[1]   Making the Case for Syringe Services Programs [J].
Adams, Jerome M. .
PUBLIC HEALTH REPORTS, 2020, 135 (1_SUPPL) :10S-12S
[2]   Barriers and Facilitators to PrEP Use Among People Who Inject Drugs in Rural Appalachia: A Qualitative Study [J].
Allen, Sean T. ;
O'Rourke, Allison ;
White, Rebecca Hamilton ;
Smith, Katherine C. ;
Weir, Brian ;
Lucas, Gregory M. ;
Sherman, Susan G. ;
Grieb, Suzanne M. .
AIDS AND BEHAVIOR, 2020, 24 (06) :1942-1950
[3]   Adherence to hepatitis B virus vaccination at syringe exchange sites [J].
Altice, FL ;
Bruce, RD ;
Walton, MR ;
Buitrago, MI .
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2005, 82 (01) :151-161
[4]  
[Anonymous], 2019, HIV - Youth, DOI 10.1097/00005768-199706001-00025
[5]  
Baillargeon J., 2020, IMPACT SUBSTANCE USE
[6]  
Behrends C.N., 1999, J ACQ IMMUN DEF SYND, V79, P76
[7]  
Belani Hrishikesh, 2012, Morbidity and Mortality Weekly Report, V61, P1
[8]   Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users [J].
Bialek, SR ;
Bower, WA ;
Mottram, K ;
Purchase, D ;
Nakano, T ;
Nainan, O ;
Williams, IT ;
Bell, BP .
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2005, 82 (03) :468-478
[9]  
Bixler D, 2018, MMWR-MORBID MORTAL W, V67, P529, DOI 10.15585/mmwr.mm6718a5
[10]   Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities [J].
Bowman, Sarah ;
Grau, Lauretta E. ;
Singer, Merrill ;
Scott, Greg ;
Heimer, Robert .
BMC PUBLIC HEALTH, 2014, 14